NCT05653752
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05653752
Title A Study of YL202 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer and Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors MediLink Therapeutics (Suzhou) Co., Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
BRCR Global Plantation Florida 33322 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Next Oncology-Dallas Irving Texas 75039 United States Details
UT health east Texas HOPE Cancer Center Tyler Texas 75701 United States Details
Next Oncology-Virginia Fairfax Virginia 22031 United States Details
Summit Cancer Center Spokane Valley Washington 99216 United States Details
Fujian Cancer Hospital Fuzhou Fujian 350014 China Details
Hunan Cancer Hospital Changsha Hunan 410013 China Details
Jilin Provincial Cancer Hospital Changchun Jilin 130012 China Details
The First Affiliated Hospital of Zhejiang University School of Medicine Hangzhou Zhejiang 310003 China Details
Zhejiang Cancer Hospital Hangzhou Zhejiang 310022 China Details
Taizhou Hospital of Zhejiang Province Taizhou Zhejiang 317099 China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field